Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Jan 15;203(2):257-258.
doi: 10.1164/rccm.202008-3139LE.

COVID-19, Hypercoagulability, and Cautiousness with Convalescent Plasma

Filippo Sanfilippo  1 , Valeria La Rosa  2 , Francesco Oliveri  1 , Marinella Astuto  1   2
Affiliations
Comment

COVID-19, Hypercoagulability, and Cautiousness with Convalescent Plasma

Filippo Sanfilippo et al. Am J Respir Crit Care Med. .
No abstract available

PubMed Disclaimer

Comment on

  • Pulmonary Angiopathy in Severe COVID-19: Physiologic, Imaging, and Hematologic Observations.
    Patel BV, Arachchillage DJ, Ridge CA, Bianchi P, Doyle JF, Garfield B, Ledot S, Morgan C, Passariello M, Price S, Singh S, Thakuria L, Trenfield S, Trimlett R, Weaver C, Wort SJ, Xu T, Padley SPG, Devaraj A, Desai SR. Patel BV, et al. Am J Respir Crit Care Med. 2020 Sep 1;202(5):690-699. doi: 10.1164/rccm.202004-1412OC. Am J Respir Crit Care Med. 2020. PMID: 32667207 Free PMC article.

References

    1. Patel BV, Arachchillage DJ, Ridge CA, Bianchi P, Doyle JF, Garfield B, et al. Pulmonary angiopathy in severe COVID-19: physiologic, imaging, and hematologic observations. Am J Respir Crit Care Med. 2020;202:690–699. - PMC - PubMed
    1. Gattinoni L, Chiumello D, Caironi P, Busana M, Romitti F, Brazzi L, et al. COVID-19 pneumonia: different respiratory treatments for different phenotypes? Intensive Care Med. 2020;46:1099–1102. - PMC - PubMed
    1. Joyner M, Wright RS, Fairweather D, Senefeld J, Bruno K, Klassen S, et al. Early safety indicators of COVID-19 convalescent plasma in 5,000 patients [preprint] medRxiv. [online ahead of print] 14 May 2020.
    1. Lozano M, Cid J, Müller TH. Plasma treated with methylene blue and light: clinical efficacy and safety profile. Transfus Med Rev. 2013;27:235–240. - PubMed
    1. Valk SJ, Piechotta V, Chai KL, Doree C, Monsef I, Wood EM, et al. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review. Cochrane Database Syst Rev. 2020;5:CD013600. - PMC - PubMed